PEDIATRICS Vol. 102 No. 1 July 1998, pp. 44-52
Cystic Fibrosis Newborn Screening: Impact on Reproductive Behavior and Implications for Genetic Counseling
Received Sep 29, 1997; accepted Jan 26, 1998.
,
,
From the * Department of Pediatrics, Medical College of
Wisconsin, Milwaukee, Wisconsin; Department of Pediatrics,
University of Arizona, Tucson Arizona; § Department of Pediatrics,
University of Wisconsin, Madison, Wisconsin; and the Genetics
Center, Children's Hospital of Wisconsin, Milwaukee Wisconsin.
Objective. To evaluate the impact of newborn screening for cystic fibrosis (CF) on the reproductive knowledge and behavior of CF families and to determine if heterozygote detection with the immunoreactive trypsinogen (IRT) method in conjunction with DNA analysis (IRT/DNA) influences knowledge and attitudes about reproduction in false-positive families.
Methods. The Wisconsin CF Neonatal Screening Project investigated 650 340 infants from 1985 to 1994 in a comprehensive randomized controlled trial to study both benefits and risks of newborn screening and to determine if early diagnosis would improve the prognosis of children with CF. Assessments of reproductive knowledge, attitudes, and behaviors of 135 families of children diagnosed as having CF in both the early treatment group and control groups were made 3 months after diagnosis using a questionnaire which was completed by 100 families. The same questionnaire was administered 1 year later to evaluate retention of information. It was completed by 71 families. A follow-up assessment tool was also administered in 1994 and responses obtained from 73 families. Knowledge, attitudes, and behavior among false-positive families were also assessed at the time of the sweat test in 206 families who experienced IRT screening and 109 families tested with the IRT/DNA method. Follow-up assessments were completed 1 year later in 106 IRT families and 63 IRT/DNA families.
Results. In families with a CF child, 95% initially understood that there was a 1 in 4 risk in subsequent pregnancies, and there was good retention of this information 1 year later. At the 1994 assessment, 52% of families had not yet conceived more children, but 74% of these already had children. In the couples in whom CF was diagnosed in the first child, 70% (95% confidence interval = 54% to 85%) conceived more children. There were 43 subsequent pregnancies in 31 families. Prenatal diagnosis was used by 26% of the families (8/31) for 21% of the pregnancies (9/43). There were 3 pregnancies with CF detected, all of which were carried to term. In the false-positive groups, >95% of families initially understood that their child definitely did not have CF. There was no difference between false-positive IRT and IRT/DNA groups, and the information was retained at 1 year. Follow-up assessment 1 year after negative sweat tests revealed that 7% of the IRT and 10% of the IRT/DNA families still thought about the results often or constantly. When asked whether the experience of screening affected feelings about having more children, an affirmative response was obtained in 4% of IRT families but in 17% of IRT/DNA families. One year later, more than half of the false-positive IRT/DNA families did not understand that they were at increased risk of having a child with CF.
Conclusions. We conclude that CF neonatal screening does not have a significant impact on the reproductive behavior of most families and that prenatal diagnosis is not used by the majority of CF families. IRT/DNA testing experiences seem to affect attitudes about having more children, and some parents are confused about the implications of the results, even with genetic counseling. However, persistent concerns about the sweat test result are limited. Questions raised by this study confirm the need for more research regarding the process of genetic counseling and its impact on reproductive attitudes and behavior in the newborn screening setting.
Key words: cystic fibrosis, newborn screening, immunoreactive trypsinogen, carrier detection, reproductive decision making, prenatal diagnosis, genetic counseling, health policy.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  F A Miller, R Z Hayeems, Y Bombard, J Little, J C Carroll, B Wilson, J Allanson, M Paynter, J P Bytautas, R Christensen, et al. Clinical obligations and public health programmes: healthcare provider reasoning about managing the incidental results of newborn screening J. Med. Ethics, October 1, 2009; 35(10): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Miller, J. S. Robert, and R. Z. Hayeems Questioning the Consensus: Managing Carrier Status Results Generated by Newborn Screening Am J Public Health, February 1, 2009; 99(2): 210 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Farrell, L. Deuster, J. Donovan, and S. Christopher Pediatric Residents' Use of Jargon During Counseling About Newborn Genetic Screening Results Pediatrics, August 1, 2008; 122(2): 243 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Farrell and P. Kuruvilla Assessment of Parental Understanding by Pediatric Residents During Counseling After Newborn Genetic Screening Arch Pediatr Adolesc Med, March 1, 2008; 162(3): 199 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bishop Hubbard Policy Issues Related to Expanded Newborn Screening: A Review of Three Genetic/Metabolic Disorders Policy Politics Nursing Practice, August 1, 2007; 8(3): 201 - 209. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Comeau, F. J. Accurso, T. B. White, P. W. Campbell III, G. Hoffman, R. B. Parad, B. S. Wilfond, M. Rosenfeld, M. K. Sontag, J. Massie, et al. Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report Pediatrics, February 1, 2007; 119(2): e495 - e518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Sawyer, B. Cerritelli, L. S. Carter, M. Cooke, J. A. Glazner, and J. Massie Changing Their Minds With Time: A Comparison of Hypothetical and Actual Reproductive Behaviors in Parents of Children With Cystic Fibrosis Pediatrics, September 1, 2006; 118(3): e649 - e656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Grosse, C. A. Boyle, A. Kenneson, M. J. Khoury, and B. S. Wilfond From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening Panels Pediatrics, March 1, 2006; 117(3): 923 - 929. [Full Text] [PDF]
|
|
|
|
|
|
K. Acharya, P. D. Ackerman, and L. F. Ross Pediatricians' Attitudes Toward Expanding Newborn Screening Pediatrics, October 1, 2005; 116(4): e476 - e484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tluczek, R. L. Koscik, P. M. Farrell, and M. J. Rock Psychosocial Risk Associated With Newborn Screening for Cystic Fibrosis: Parents' Experience While Awaiting the Sweat-Test Appointment Pediatrics, June 1, 2005; 115(6): 1692 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Sawyer and J. A. Glazner What Follows Newborn Screening? An Evaluation of a Residential Education Program for Parents of Infants With Newly Diagnosed Cystic Fibrosis Pediatrics, August 1, 2004; 114(2): 411 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J C Polnay, A Davidge, C. Lyn U, and A R Smyth Parental attitudes: antenatal diagnosis of cystic fibrosis Arch. Dis. Child., October 1, 2002; 87(4): 284 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Twomey Considerations for Policies Regarding Genetic Testing of Children Policy Politics Nursing Practice, May 1, 2002; 3(2): 140 - 148. [Abstract] [PDF]
|
|
|
|
|
|
Committee on Bioethics Ethical Issues With Genetic Testing in Pediatrics Pediatrics, June 1, 2001; 107(6): 1451 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Ciske, A. Haavisto, A. Laxova, L. Z. M. Rock, and P. M. Farrell Genetic Counseling and Neonatal Screening for Cystic Fibrosis: An Assessment of the Communication Process Pediatrics, April 1, 2001; 107(4): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Farrell, L. K. Certain, and P. M. Farrell Genetic Counseling and Risk Communication Services of Newborn Screening Programs Arch Pediatr Adolesc Med, February 1, 2001; 155(2): 120 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dudding, B. Wilcken, B. Burgess, J. Hambly, and G. Turner Reproductive decisions after neonatal screening identifies cystic fibrosis Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 124F - 127. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. M Farrell Early diagnosis of cystic fibrosis can improve children's growth BMJ, October 10, 1998; 317(7164): 1017 - 1017. [Full Text]
|
|
